2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Finerenone and Renal Oxidative Stress Finerenone 20 MG Oral Tablet, Placebo - Type2diabetes | Phase 3 | Completed | University of Erlangen-Nürnberg Medical School | 91 | 2024-01-18 | 2026-04-02 |
| Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin Hydrochloride extended release 1000 mg, Pioglitazone 30mg - Type2diabetes | Phase 3 | Completed | University of Basrah | 243 | 2023-11-01 | 2025-03-30 |
Insulin Glargine (1) · Pioglitazone (1) · Tablets (1) · finerenone (1) · saxagliptin (1)
University of Basrah (1) · University of Erlangen-Nürnberg Medical School (1)
Germany (1) · Iraq (1)
Dennis Kannenkeril, MD (1) · Haider A Alidrisi, MD (1) · Roland E. Schmieder, MD (1)